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ABSTRACT 28 
Exopolysaccharides (EPS) isolated from two Bifidobacterium strains, one of human 29 
intestinal origin (Bifidobacterium longum subsp. longum IPLA E44) and the other from dairy 30 
origin (Bifidobacterium animalis subsp. lactis IPLA R1), were subjected to in vitro chemically 31 
simulated gastrointestinal digestion, which showed the absence of degradation of both polymers 32 
in these conditions. Polymers were then used as carbon sources in pH-controlled faecal batch 33 
cultures and compared with the non-prebiotic carbohydrate glucose and the prebiotic inulin to 34 
determine changes in the composition of faecal bacteria. A set of eight fluorescent in situ 35 
hybridisation oligonucleotide probes targeting 16S rRNA sequences were used to quantify 36 
specific groups of microorganisms. Growth of the opportunistic pathogen Clostridium 37 
histolyticum occurred with all carbohydrates tested similarly to that found in negative control 38 
cultures without added carbohydrate and was mainly attributed to the culture conditions used 39 
rather than enhancement of growth by these substrates. Polymers E44 and R1 stimulated growth 40 
of Lactobacillus / Enterococcus, Bifidobacterium, and Bacteroides / Prevotella in a similar way to 41 
that seen with inulin. The EPS R1 also promoted growth of the Atopobium cluster during the first 42 
24 h of fermentation. An increase in acetic and lactic acids was found during early stages of 43 
fermentation (first 10-24 h) correlating with increases of Lactobacillus, Bifidobacterium, and 44 
Atopobium. Propionic acid concentrations increased in old cultures, which was coincident with 45 
the enrichment of Clostridium cluster IX in cultures with EPS R1 and with the increases in 46 
Bacteroides in cultures with both microbial EPS (R1 and E44) and inulin. The lowest acetic to 47 
propionic acids ratio was obtained for EPS E44. None of the carbohydrates tested supported the 48 
growth of microorganisms from Clostridium clusters XIVa+b and IV, results that correlated with 49 
the poor butyrate production in the presence of EPS. Thus, EPS synthesized by bifidobacteria 50 
from dairy and intestinal origins can modulate the intestinal microbiota in vitro, promoting 51 
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changes in some numerically and metabolically relevant microbial populations and shifts in the 52 
production of short chain fatty acids. 53 
54 
 4 
INTRODUCTION  55 
The human colonic microbiota is a complex ecosystem dominated by obligate anaerobes 56 
that can reach levels of over 10
11
 cells per gram of contents (Bäckhed et al., 2005). Dietary 57 
compounds not digested by the host are the main carbon source from which gut microorganisms 58 
obtain energy. These substrates, which mainly include plant oligo and polysaccharides, can be 59 
subjected to gut bacterial metabolic transformations and hence they can have a major influence on 60 
human nutrition and health (Flint et al., 2008). Short chain fatty acids (SCFA) and lactate are the 61 
main products arising from the microbial fermentation of carbohydrates. SCFA can provide 62 
energy to the colonic epithelium, modulate cholesterol and lipid metabolism, suppress pathogenic 63 
intestinal bacteria and modulate the immune system (Cummings and Macfarlane, 1997; Topping 64 
and Clifton, 2001). Chemical composition and availability of fermentable carbohydrates in the 65 
colon have a strong influence on the gut microbiota composition. Specific carbohydrates are now 66 
being used as prebiotics based on the concept that they stimulate selected beneficial bacteria in the 67 
colon (Gibson and Roberfroid, 1995). The most studied prebiotics are inulin and 68 
fructooligosaccharides (FOS) (Roberfroid, 2007), and they have a recognised bifidogenic effect 69 
(Bouhnik et al., 2004; Gibson et al., 1995; Kruse et al., 1999; Rossi et al., 2005).  70 
Many strains of lactic acid bacteria and bifidobacteria are able to produce 71 
exopolysaccharides (EPS). The physiological functions of these carbohydrate polymers have not 72 
yet been clearly determined (Ruas-Madiedo et al., 2008). Among the beneficial effects attributed 73 
to these biopolymers such as cholesterol lowering capability and immunomodulating ability, the 74 
possibility of acting as fermentable substrates in vitro has been demonstrated to date by Korakli 75 
and coworkers (Korakli et al., 2002) for a fructan-type EPS produced by a strain of Lactobacillus 76 
sanfranciscensis. There was also evidence of an in vitro bifidogenic effect for the levan-type EPS 77 
produced by another strain of the same species (Dal Bello et al., 2001). We have recently 78 
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demonstrated in a non pH-controlled faecal slurry culture that EPS isolated from different human 79 
intestinal bifidobacteria can act as fermentable substrates for microbial intestinal populations 80 
(Salazar et al., 2008). This promoted shifts in SCFA profiles, moderate increases in bifidobacteria 81 
populations, and changes in banding patterns when cultures were analysed by PCR-DGGE using 82 
universal primers, which indicated microbial population shifts.  83 
Bifidobacteria are intestinal microorganisms that are being extensively used as probiotics, 84 
based on health-promoting benefits attributed to them (Masco et al., 2005). In order to gain 85 
further insight into the changes that EPS from bifidobacteria may mediate in the intestinal 86 
microbiota, in the present work we quantified modifications in the levels of selected microbial 87 
groups by fluorescent in situ hybridisation (FISH) and established possible relationships between 88 
metabolic changes and variations in microbial populations by using pH-controlled faecal batch 89 
cultures. Compared to our previous non pH-controlled experiments (Salazar et al., 2008), this 90 
design is a more realistic simulation of the conditions in the human distal colon with regards to 91 
local pH, substrate availability and transit time, as the semisolid luminal contents of the distal 92 
colon are almost static therein. Two microbial polymers were used in this study as carbon sources; 93 
EPS E44 was produced by a human faecal isolate of Bifidobacterium longum subsp. longum, one 94 
of the most abundant species of Bifidobacterium found in the faecal samples of donors from our 95 
region (Asturias, North of Spain) (Delgado et al., 2006). This EPS was chosen on the basis of the 96 
high reduction of acetic to propionic acid ratio promoted by polymers of the species B. longum 97 
and particularly by E44 (Salazar et al., 2008). The EPS R1 was produced by a strain of 98 
Bifidobacterium animalis subsp. lactis, species widely used as adjunct culture in functional dairy 99 
products. Cultures of B. animalis subsp. lactis IPLA R1 present a ropy phenotype which could be 100 
an interesting technological property (Salazar et al., 2009). Both strains were considered in order 101 
to ascertain if the origin of the EPS producing strain and their different monosaccharide  102 
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composition could influence microbiota dynamics. The use of bifidobacteria producing 103 
fermentable EPS may have the advantage over other known prebiotic substrates of the use / 104 
administration of both, a potential probiotic and a fermentable substrate, in a single step.  105 
 106 
MATERIAL AND METHODS 107 
EPS-producing strains and culture conditions 108 
B. longum subsp. longum IPLA E44 was previously isolated from faeces of a healthy adult 109 
volunteer with the approval of the Regional Ethics Committee (Asturias, Spain; Delgado et al., 110 
2006). B. animalis subsp. lactis IPLA R1 was of dairy origin (Ruas-Madiedo et al., 2006). Both 111 
strains are held in the IPLA’s culture collection. Strains identity was confirmed by partial 112 
amplification of the 16S rRNA gene using primers Y1-Y2 (Young et al., 1991), sequencing and 113 
alignment with sequences from reference strains held in the GenBank database. Bifidobacteria 114 
were grown in MRSC broth (MRS broth [Difco, Becton Dickinson, MD, USA] supplemented 115 
with 0.25% [w/v] L-cysteine [Sigma Chemical Co., St. Louis, MO]) and were incubated at 37ºC 116 
for 24 h in an anaerobic cabinet (Mac 1000; Don Whitley Scientific, West Yorkshire, UK) under a 117 
10% H2, 10% CO2, and 80% N2 atmosphere.  118 
 119 
EPS isolation 120 
EPS fractions produced by Bifidobacterium strains were isolated from the cellular biomass 121 
harvested from MRSC agar plates (Ruas-Madiedo et al., 2006). Bacteria were grown by creating a 122 
culture lawn with sterile glass beads on the surface of MRSC agar plates that were then incubated 123 
under anaerobic conditions at 37ºC for 5 days. Cell biomass was collected using 2 mL ultrapure 124 
water per plate and the resulting volume mixed with 1 vol of 2 M NaOH. The suspension was 125 
gently stirred overnight at room temperature to promote polymer release from the cellular surface. 126 
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Cells were removed by centrifugation at 8,400 x g for 30 min and EPS was precipitated from the 127 
supernatants over 48 h at 4ºC using 2 vol of cold absolute ethanol. Following centrifugation, the 128 
EPS fraction was resuspended in ultrapure water and dialysed for 3 days at 4ºC with daily changes 129 
of water, using dialysis tubes (Sigma) of 12 to 14 kDa molecular mass cut off. Finally, the 130 
dialysed EPS fractions were freeze-dried.  131 
 132 
Chemical simulation of the EPS gastrointestinal transit 133 
The digestibility of EPS through the gastrointestinal tract was studied using an in vitro 134 
model that chemically simulates the physiological conditions. The simulated gastric juice 135 
contained 125 mM NaCl, 7 mM KCl, 45 mM NaHCO3, and 3 g/L pepsin (Sigma) pH 2.0 adjusted 136 
with HCl, and the simulated intestinal juice was composed of  0.3% (w/v) bovine bile, and 0.1% 137 
(w/v) pancreatin (Sigma) pH 8.0 adjusted with 10 N NaOH. The EPS fractions were weighted and 138 
dissolved at a concentration of 10 mg/mL in ultra-pure water. Two different simulations were 139 
carried out independently, one mimicking gastric digestion and the other simulating small 140 
intestine digestion. In both cases 100 L EPS solution were mixed with 900 L of either gastric 141 
or intestinal juice for obtaining a final concentration in the experiment of 1 mg/mL EPS , which 142 
has been the lowest dose tested by us in a previous work having any effect (Ruas-Madiedo et al., 143 
2006). The suspension in gastric juice  was incubated for 90 min at 37ºC with a mild stirring and 144 
finally the pH was brought to 4.5-5.0 with 10 N NaOH, and the suspension in intestinal juice was 145 
incubated for 120 min at 37ºC in anaerobic conditions. Samples were then centrifuged (10,000 x 146 
g) for 10 min and supernatants collected for size exclusion chromatography (SEC) analyses.  147 
A HPLC chromatographic system composed of an Alliance 2690 module injector, a 148 
Photodiode Array PDA 996 detector, a 410 refractive index (RI) detector and the Empower 149 
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software (Waters, Milford, MA, USA) was used. Additionally, a multi-angle laser light scattering 150 
detector (MALLS) (Dawn Heleos II, Wyatt Europe GmbH, Dembach, Germany) was coupled in 151 
series. The sample separation (50 L vol injection) was carried out in two SEC columns placed in 152 
series, TSK-Gel G3000 PWXL + TSK-Gel G5000 PWXL protected with a TSK-Gel guard column 153 
(Supelco-Sigma). The mobile phase was 0.1 M NaNO3 and the separations took place at 40ºC at a 154 
flow rate of 0.45 mL/min. The EPS peaks were detected and quantified with the RI detector. 155 
Standards of dextran (Fluka-Sigma), ranging from 5x10
3
 to 4.9x10
6
 Da, were used for EPS 156 
quantification. The molar mass (Mw) was determined by using the MALLS detector. Assays were 157 
carried out in triplicate and HPLC runs were performed in duplicate.  158 
 159 
Faecal sample preparation  160 
Faecal samples were obtained from three healthy adult donors (two men and one woman, 161 
aged 31 to 40 years) who were free from known metabolic and gastrointestinal disorders. None of 162 
the volunteers had taken antibiotics during the 6 months leading to the study. Samples were 163 
collected, kept in anaerobic cabinet and used within a maximum of 15 min after collection. A 1/10 164 
w/v dilution in pre-reduced phosphate-buffered saline solution (PBS: 8 g/L  NaCl, 0.2 g/L KCl, 165 
1.15 g/L Na2HPO4, and 0.2 g/L KH2PO4) pH 7.3 was prepared and homogenised in a stomacher 166 
(Seward, UK)  for 2 min. 167 
 168 
Batch culture fermentations   169 
Five gently stirred pH-controlled batch fermenter (80 mL working volume) were run in 170 
parallel, in which each of the following carbohydrates were added: EPS isolated from the strains 171 
B. animalis IPLA R1 and B. longum IPLA E44, inulin (Beneo  ST, Orafti, Tienen, Belgium; low 172 
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molecular weight inulin > 90%, average DP  10, glucose + fructose  4%, sucrose  8%) or 173 
glucose (non-selective control). A control with no carbohydrate added (negative control) was also 174 
included. The experiment was performed in triplicate, using one faecal sample given by a 175 
different donor for each run of five batch fermenters.  Eighteen mL of sterile basal medium (BM) 176 
were aseptically added to each fermenter. Briefly, BM contained 2 g/L peptone water (Oxoid Ltd., 177 
Basingstoke, UK), 2 g/L yeast extract (Oxoid), 0.1 g/L NaCl (BDH Chemical Ltd., Dorset, UK),  178 
0.04 g/L KH2P04 (BDH), 0.04 g/L K2HP04 (BDH), 0.01 g/L MgS04·7H20 (BDH), 0.01 g/L 179 
CaCl2·6H20 (BDH), 2 g/L NaHC03 (BDH), 2 mL Tween-80 (BDH), 0.05 g/L haemin solution 180 
(Sigma), 10 µL Vitamin K1 (Sigma), 0.5 g/L L-cysteine (Sigma) HCl, 0.5 g/L bile salts (Oxoid), 181 
and 4 mL resazurin 0.025 % w/v as an anaerobic indicator. The fermenters were sparged 182 
overnight with O2-free N2 at 15 mL/min.  183 
The test carbohydrates (1% w/v) were added to each vessel just before the addition of 2 184 
mL (10% v/v) of faecal slurry prepared as described above. The temperature was kept at 37ºC by 185 
means of a circulating water bath and the pH was maintained between 6.7 and 6.9 using an 186 
Electrolab pH controller (Tewkesbury, UK). The batch cultures were run for a period of 72 h and 187 
2 mL samples were obtained from each vessel at 0, 10, 24, 34, and 48 h for FISH and SCFA 188 
analyses. A further sample was obtained at 72 h for SCFA analyses.  189 
 190 
Enumeration of bacteria in faecal cultures using FISH 191 
The FISH technique was used to quantify selected bacterial groups of the gut microbiota 192 
following the method described by Daims et al. (2005). Samples (375 µL) obtained from each 193 
vessel at each sampling time were fixed for 6 at 4ºC with 1.125 mL of 4% (w/v) filtered 194 
paraformaldehyde (pH 7.2). Fixed cells were centrifuged at 15,000 x g for 5 min and washed 195 
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twice in filtered PBS. The washed cells were finally suspended in a mixture of 150 µL filtered 196 
PBS and 150 µL (99%) ethanol  and stored at -20ºC for at least 1 h before further processing. The 197 
samples were then diluted in a suitable volume of filtered PBS in order to obtain 10-100 198 
fluorescent cells in each microscope field of view and 20 µL of the above solution was added to 199 
each well of a 6 well Teflon/poly-L-lysine coated slide (Tekdon Ins., Myakka City, USA). The 200 
samples were dried for 15 min in a drying chamber (46ºC). They were then dehydrated using an 201 
alcohol washing series (50, 80 and 96% [v/v] ethanol) for 3 min with each solution. Slides were 202 
returned to the drying oven for 2 min to evaporate the excess ethanol before adding the 203 
hybridisation mixture. Lab158 probe required a pre-treatment with 20 µL lysozyme (1 mg/mL) at 204 
37ºC for 15 min. Following incubation the slides were washed briefly (2-3 s) in distilled water to 205 
remove the lysozyme solution and were then dehydrated in the ethanol series as described above. 206 
Synthetic oligonucleotide probes targeting specific regions of the 16S rRNA gene labelled 207 
with the fluorescent dye Cy3 (Sigma), were utilized for the enumeration of the Bifidobacterium 208 
genus, Bacteroides/ Prevotella  group, Lactobacillus/ Enterococcus group, Clostridium coccoides/ 209 
Eubacterium rectale group (Clostridium clusters XIVa + b), Clostridium histolyticum subgroup 210 
(clusters I and II), Clostridium cluster IX,  Faecalibacterium prausnitzii and relatives (part of 211 
Clostridium cluster IV), and Atopobium cluster (Table 1). For the enumeration of total cells, 212 
samples were stained with the nucleic acid stain 4´, 6-diamidino -2-phenylindole (DAPI).  213 
50 µL of the hybridisation mixture (5 L of each probe [50 ng/µL] and 45 µL of filtered 214 
hybridisation buffer [0.9 M NaCl, 20 mM Tris-HCl pH 8.0, 0.01% SDS w/v]) were added to each 215 
well and allowed to hybridise for 4 h in a microarray hybridisation incubator (Grant Boekel, 216 
Cambridge, UK). Following hybridisation, slides were washed in 50 mL of filtered washing 217 
buffer (0.9 M NaCl, 20 mM Tris-HCl pH 8.0) for 15 min. They were then dipped in cold water for 218 
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a few seconds and dried with compressed air. 5 µL of antifade reagent (polyvinyl alcohol 219 
mounting medium with DABCO  antifading, Sigma) was added to each well and a coverslip was 220 
applied (20 mm coverslips, thickness nº 1, VWR, Lutterworth, UK). Slides were stored in the 221 
dark at 4ºC for a maximum of 3 days and during this time were examined using an 222 
epifluorescence microscope Nikon Eclipse 400 (Nikon, Surrey, UK) using the Fluor 100 lens. 223 
Filters for the DAPI stain (excitation at 550 nm and emission at 461 nm) and the Cy3 dye 224 
(excitation at 550 nm and emission at 564 nm) were used. A minimum of 15 fields of view were 225 
counted for each sample. Numbers of specific bacteria and DAPI-stained entities (used to count 226 
total bacteria) were determined using the following equation:  227 
 DF x ACC x 6732.42 x 50 x DFsample  228 
where DF is the dilution factor (300/375 = 0.8) and ACC is the average cell count of 15 fields of 229 
view. The figure 6732.42 refers to the area of the well divided by the area of the field of view. 230 
The factor 50 takes the cell count back to per millilitre of sample and DFsample refers to the 231 
dilution of sample used with a particular probe or stain. 232 
 233 
Analysis of SCFA and lactic acid 234 
Samples (1 mL) were centrifuged twice (17,000 x g) for 15 min to remove cells and 235 
particulate materials. The supernatant (20 µL) was injected into a HPLC system (Hewlett-Packard 236 
HP 1050 series) equipped with a UV detector set at 210 and an automatic injector. An ion-237 
exclusion REZEX-ROA organic acid column (Phenomenex Inc., Macclesfield, UK) was used, 238 
which was maintained at 83.2ºC with a column heater. The eluent, 0.0025 M sulphuric acid in 239 
HPLC-grade water, was pumped through the column at a flow rate of 0.5 mL/min. Data from the 240 
UV detector were integrated using the ValueChrom
TM
 software package (BioRad). The 241 
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concentration (mM) of each SCFA and lactate was calculated using linear regression equations 242 
(R
2
  0.99) from the corresponding curves of standards obtained with six different concentrations. 243 
Total SCFA concentrations were calculated as the sum of the three major SCFA (acetic acid plus 244 
propionic acid plus butyric acid). The percent of total SCFA for each of the three major SCFA 245 
was also calculated from total SCFA concentration and the concentration of the corresponding 246 
SCFA.  247 
 248 
Statistical analysis 249 
 Statistical analysis was performed using the SPSS-PC 11.0 software (SPSS Inc., Chicago, 250 
Illinois, USA). Data of simulated gastrointestinal digestion were subjected to a one-way ANOVA. 251 
For the FISH data, growth of microbial groups targeted by each probe was evaluated by a one-252 
way ANOVA in order to determine whether there were significant differences at a given 253 
fermentation time among the substrates evaluated by using “carbohydrate” as a factor with five 254 
categories (negative control, EPS R1, EPS E44, inulin, and glucose); where appropriate, the least 255 
significant difference test (LSD) was used for comparison of means. Another One-way ANOVA 256 
and LSD test were performed in order to determine whether there was any significant difference 257 
among times of fermentation for each specific carbohydrate by using “time of incubation” as 258 
factor with five categories (0, 10, 24, 34, and 48 h).  259 
 260 
RESULTS 261 
Susceptibility of EPS to degradation under simulated gastrointestinal conditions 262 
 Susceptibility of the EPS E44 and R1 to simulated gastric and intestinal juices was 263 
evaluated by possible modifications on the amount of EPS recovered before and after submission 264 
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to treatments. The amount of the highest peak of both EPS fractions (7.4 ± 2.50 x 10
5
 g/mol and 265 
1.55 ± 0.20 x 10
6
 g/mol, for E44 and R1, respectively) recovered from SEC did not show 266 
significant variation after any treatment (Fig. 1). Thereby, E44 and R1 were not degraded during 267 
submission to simulated gastric and intestinal conditions.  268 
 269 
Changes in faecal populations by FISH analysis  270 
In vitro modification of the faecal microbiota by EPS, inulin and glucose was monitored 271 
by FISH (Table 2. In the negative control cultures, most bacterial groups remained without 272 
significant variation throughout fermentation. The exception was Atopobium cluster and C. 273 
histolyticum group for which a significant decrease and increase (P < 0.05) was observed, 274 
respectively, at 48 h and from 10 h of incubation with respect to 0 h. In contrast, the addition of 275 
carbohydrates led to more noticeable changes in the faecal microbiota. The addition of glucose 276 
and the EPS R1 and E44 promoted an increase of total bacteria during incubation (from 10 h of 277 
fermentation with respect to 0 h; (P < 0.05). Relating the specific microbial groups, Lactobacillus 278 
/ Enterococcus, Bifidobacterium, and Bacteroides / Prevotella showed a similar behaviour with 279 
all carbohydrates tested. Therefore, they were the only bacterial groups out of the eight 280 
enumerated that increased significantly (P < 0.05) during batch culture fermentations (from 10, 24 281 
and 48 h of incubation for each of the three groups, respectively) with inulin, glucose and with the 282 
EPS isolated from B. animalis IPLA R1 and B. longum IPLA E44 as compared to the negative 283 
control cultures. However, probably because of the variations between donors, the comparison 284 
with 0 h within the same culture did not render significant differences through fermentation (10, 285 
24, 34, and 48 h of incubation) for Bifidobacterium with EPS E44 and for Bacteroides / 286 
Prevotella with R1.  287 
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Clostridium cluster IX and Atopobium group displayed different behaviour depending on 288 
the carbohydrate. Thus, the Clostridium cluster IX became enriched from 10 to 48 h in cultures 289 
with glucose and with the EPS R1 compared with 0 h (P < 0.01). Polymer R1 also promoted 290 
growth of the Atopobium group at 10 and 24 h of incubation with respect to time 0 (P < 0.05). 291 
This group of microorganisms decreased from this point to the end of fermentation (48 h) in a 292 
similar way to that of the negative control (P < 0.05). Remarkably, neither EPS E44 nor inulin 293 
had any effect on Clostridium cluster IX and Atopobium. C. histolyticum group displayed 294 
significant increases up to 48 h of fermentation with respect to 0 h with all test carbohydrates (P < 295 
0.05) as it was also found in negative control cultures (P < 0.001). Finally, no major differences 296 
were seen in Clostridium cluster XIVa+b, and the F. prausnitzii group when assessing the effect 297 
of inulin, glucose and the two microbial EPS during incubation, either when the test 298 
carbohydrates were compared to each other or to the negative controls.   299 
 300 
SCFA and lactate production in batch cultures 301 
Marked differences were found among donors with respect to levels of SCFA and lactate 302 
attained in faecal cultures. Because of this, data are presented separately for each donor and a 303 
statistical analysis was not carried out. The production of lactic acid was higher in the presence of 304 
the test carbohydrates compared to the negative control cultures, which indicated that 305 
carbohydrates were actively fermented by the faecal microbiota (Table 3). Lactic acid production 306 
in faecal cultures from individuals 2 and 3 occurred during early stages of fermentation and 307 
maximum levels were achieved at 10 h, with the exception of donor 2 with inulin. In faecal 308 
cultures from donor 1, the highest lactic acid production occurred later (48 h of incubation) for 309 
EPS E44 and inulin. The fermentation of EPS E44 gave rise to more lactic acid production during 310 
incubations than EPS R1 (maximum values attained during fermentation by cultures from 311 
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different donors ranged from 3.63 to 16.74 mM and from 2.29 to 3.30 mM for E44 and R1, 312 
respectively), probably indicating a more efficient utilisation of the former polymer by the 313 
intestinal microbiota.  314 
In general, total SCFA increased during faecal batch culture fermentation in both the 315 
presence and absence of the test substrates (Table 4). However, this increase was considerably 316 
more pronounced in the presence of carbohydrates than in negative controls, thus stimulating 317 
SCFA production from the external carbon sources. Acetic acid (Table 4) was the most abundant 318 
SCFA, followed by propionic acid and considerable lower amounts of butyric acid (Table 4). 319 
Although in general the absolute concentration of each of the three major SCFAs increased during 320 
incubation (data not shown) with respect to time 0, the percent of acetic acid with each 321 
carbohydrate decreased in most cases from 10 to 72 h of incubation and the contrary occurred for 322 
propionic acid, whose percent seems to increase throughout the fermentations. When absolute 323 
molar concentrations of propionic acid in the test substrate cultures and in different donors were 324 
considered, it appears that a higher production of this acid at 72 h of incubation with respect to 0 h 325 
occurred in the presence of the EPS E44 than with the other carbon sources tested (Table 3). The 326 
contrary was found for glucose which resulted in the lowest increase of propionic acid. As a 327 
consequence of the SCFA production pattern indicated above, the acetic acid to propionic acid 328 
ratio  decreased from early stages (0-10 h) to the end of incubation (72 h) (Table 4). Notably, the 329 
lowest values of this ratio among the carbohydrates tested were obtained in cultures with EPS E44 330 
and the highest in cultures with glucose. Finally, butyric acid production differed among 331 
carbohydrates, reaching the highest levels in the presence of inulin rather than in the presence of 332 
microbial EPS.  333 
 334 
DISCUSSION 335 
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We recently demonstrated that EPS isolated from bifidobacteria of human origin could act 336 
as fermentable substrates for intestinal bacteria and qualitative rearrangements of several 337 
microbial populations were evidenced by PCR-DGGE (Salazar et al., 2008). However, EPS could 338 
only act as fermentable substrates for colonic bacteria if they arrive not degraded to the colon. 339 
Under the conditions used in our study, EPS E44 and R1 did not suffer an in vitro breakdown by 340 
simulated gastric and intestinal juices. This means that long molecules (Mw > 10
6
 g/mol) may still 341 
remain available for fermentation in the colon if they are ingested, as could be the case of the 342 
polymer R1 which is synthesized by a strain of dairy origin. To this respect, other authors 343 
indicated that EPS from lactic acid bacteria can be either partially broken down (Mozzi et al., 344 
2009) or be resistant to the harsh conditions of gastrointestinal transit (Looijesteijn et al., 2001). 345 
Then, we used FISH to monitor quantitative changes in the composition of certain numerically 346 
predominant faecal microbial groups in pH-controlled batch cultures from faeces and EPS. Our 347 
results were compared with inulin and glucose, used as positive selective and non-selective 348 
controls, respectively. Glucose is not abundant in the colon and presumably its influence in the 349 
ecological intestinal ecosystem would be negligible. However, complex polymers such as inulin 350 
can be present in the diet reaching the colon undigested.  351 
Polymers produced by B. animalis subsp. lactis IPLA R1 and B. longum subsp. longum 352 
IPLA E44 are heteropolysaccharides as indicated in previous studies (Ruas-Madiedo et al., 2007). 353 
The content of monosaccharides differed between both polymers, with EPS R1 composed of 354 
rhamnose, galactose and glucose whereas E44 contained glucose and galactose, but not rhamnose. 355 
Since different microbial glycosidases and mono and oligosaccharides cell-transport systems are 356 
needed for the use of polysaccharides, it could be assumed that differences in composition of both 357 
polymers could account for some of the differences observed in the response of the faecal 358 
microbiota in the presence of EPS in the present work.  359 
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 The presence of both microbial EPS tested in this work promoted an increase of total 360 
bacteria during fermentation. An increase in C. histolyticum occurred in the presence of all 361 
carbohydrates tested including in negative controls and as such could be attributed to factors such 362 
as culture conditions rather than to a specific effect mediated by the test substrates. Among the 363 
other groups analysed by FISH, E44 and R1 clearly stimulated the growth of Lactobacillus / 364 
Enteroccoccus and the genus Bifidobacterium, which corroborated our previous findings with 365 
regards to the increase of bifidobacteria population by quantitative RT-PCR (Salazar et al., 2008). 366 
Bifidobacteria and lactobacilli have been traditionally considered as the main microbial targets of 367 
prebiotic action (Gibson and Roberfroid, 1995; Reid, 2008). At this point it is necessary to take 368 
into account that no a totally specific probe targeting most species of Lactobacillus genus but 369 
discarding enterococci is currently available; in spite of that, Lab 158 was chosen for the present 370 
work on the basis of its good performance with common intestinal lactobacilli (Harmsen et al., 371 
1999). Therefore, as the Lab158 probe enumerates both lactobacilli and enterococci (Harmsen et 372 
al., 1999), a concomitant increase of enterococci should not be from our results. Inulin and inulin-373 
derived substrates have previously been reported by other authors to enhance the growth of 374 
bifidobacteria and lactobacilli (Hopkins and Macfarlane, 2003; Wang and Gibson, 1993). Here 375 
also, both inulin and glucose stimulated growth of Lactobacillus / Enterococcus and 376 
Bifidobacterium groups. To date, the prebiotic effect of EPS produced by lactic acid bacteria has 377 
only been demonstrated for two fructan-type homopolysaccharides produced by Lactobacillus 378 
sanfranciscensis (Dal Bello et al., 2001; Korakli et al., 2002). To the best of our knowledge, 379 
polymers R1 and E44 are the first heteropolysaccharides for which a stimulatory effect on 380 
intestinal bifidobacteria and lactobacilli populations has been documented.  381 
Bifidobacteria, lactobacilli and some microorganisms of the Atopobium cluster (Dewhirst 382 
et al., 2001; Downes et al., 2001) are lactic acid producers; acetic acid is formed by many 383 
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anaerobic bacteria from the human gut (Macfarlane and Gibson, 1997), also being a principal end 384 
product of carbohydrate fermentation by bifidobacteria. In faecal cultures with EPS, inulin and 385 
glucose added, the rapid increase in acetic and lactic acids during early stages of fermentation 386 
(until 10 h and in certain cases until 24 h of fermentation) correlated well with the increase of 387 
total bacterial counts as well as with increases in lactobacilli and bifidobacteria together with 388 
increases in Atopobium with R1 occurring at those times. The production of lactic and acetic acids 389 
by the groups of microorganisms commented above (lactobacilli, bifidobacteria and Atopobium 390 
cluster) could account for metabolic cross-feeding mechanisms that could probably occur among 391 
lactic acid bacteria and other faecal microbial groups (Salazar et al., 2008).  392 
Bacteroides and Prevotella are among the predominant genera in the gut of mammals 393 
(Hooper et al., 2002). They are versatile saccharolytic microorganisms and the major part of 394 
polysaccharide digestion that occurs in the human large intestine is carried out by members of the 395 
genus Bacteroides (Salyers, 1984). Therefore, it can be assumed that they could play a key role in 396 
the degradation of the carbohydrate sources used in pH-controlled fermentations. As expected, 397 
polymers R1, E44 and inulin promoted growth of Bacteroides / Prevotella group in faecal 398 
cultures. These results may explain the variations and rearrangements detected previously by us in 399 
members of these microbial groups by PCR-DGGE when faecal bacteria were incubated in the 400 
presence of EPS from intestinal bifidobacteria in a non pH-controlled batch culture (Salazar et al., 401 
2008). Changes in microbial levels as well as in the different species populations of Bacteroides / 402 
Prevotella group may be affecting other microoganisms of the complex colonic ecosystem and the 403 
metabolic activities occurring therein (van Tongeren et al., 2005).   404 
Our previous data suggested that the propionic acid production and therefore the acetic / 405 
propionic acid ratio could be shifted by the incubation of faecal microorganisms in the presence of 406 
EPS (Salazar et al., 2008). In an attempt to correlate shifts in SCFA with changes in faecal 407 
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bacteria populations, we used the probe Prop 853 to monitor variations in the Clostridium cluster 408 
IX since many intestinal propionate-producing bacteria fall within this group of microorganisms 409 
(Walker et al., 2005). Clostridium cluster IX only became enriched in the presence of the polymer 410 
R1 and glucose. Therefore, stimulation of this group of microorganisms may account for the 411 
production of propionate when EPS R1 was present. The increase in Bacteroides, a group 412 
producing variable amounts of propionate depending on the culture conditions (Macfarlane and 413 
Gibson, 1997), in the presence of both microbial EPS and inulin, also provides a probable 414 
rationale for the increase of propionic acid and decrease of the acetic to propionic acid ratio 415 
observed in later cultures (72 h) with these carbohydrates. A reduction in the acetic to propionic 416 
acid ratio has been proposed as an indicator of a potential hypolipidemic effect of prebiotics 417 
(Delzenne and Kok, 2001). The highest levels of propionic acid and lowest values of the acetic to 418 
propionic acid ratio among the four carbohydrates tested were obtained for EPS E44 and the 419 
lowest levels of propionic and highest acetic to propionic acid ratio with glucose. These data 420 
corroborate our previous findings with the same EPS E44 in non pH-controlled batch cultures 421 
(Salazar et al., 2008).  422 
The majority of butyrate-producing bacteria are thought to be included in Clostridium 423 
clusters XIVa+b and IV. Roseburia / Eubacterium rectale and Faecalibacterium groups, 424 
belonging to the first and second clusters respectively, are probably the most prolific butyrate 425 
producers in the human colon (Barcenilla et al., 2000; Hold et al., 2003; Pryde et al., 2002). In our 426 
study, neither of the EPS tested nor inulin or glucose supported the growth of microorganisms 427 
from clusters XIVa+b and IV. The behaviour of these faecal microbial groups was in agreement 428 
with the poor butyrate production mediated by EPS but did not provide a rationale for moderately 429 
higher levels of this SCFA obtained with inulin. It has been reported that pH values around 6.5 – 430 
 20 
7.0 such as those used in the present work can impair butyrate production and promote propionic 431 
acid formation by intestinal microbiota (Walker et al., 2005).  432 
In spite of major similarities found between both microbial EPS analysed in our study with 433 
respect to their role as fermentable substrates by the colonic microbiota, some differences in their 434 
fermentation performances should be highlighted. Thus, polymer R1 but not E44, promoted a 435 
slight increase of Atopobium and Clostridium cluster IX groups during fermentation, suggesting a 436 
broader range of potential microbial fermenters for the former carbohydrate. However, the higher 437 
levels of SCFA and the lower acetic to propionic acid ratio obtained with E44 with respect to R1 438 
points towards a more efficient utilisation of E44 as carbon source. Whether differences between 439 
both substrates are related to their different chemical composition and origin, cannot be clearly 440 
concluded from the present data and deserve further attention.  441 
Relating the production of EPS in food and in vivo environments, polymer R1 may be 442 
synthesized by the producer strain during food fermentation if the strain is included as adjunct 443 
culture. On the other hand, although the synthesis of EPS by bifidobacteria in the intestinal 444 
environment has not been demonstrated yet, we recently reported the induction in vitro of EPS 445 
synthesis by bile in Bifidobacterium (Ruas-Madiedo et al., 2009). In this way, bile or other 446 
stressing factors of the gastrointestinal tract could act as triggering agents of the synthesis of these 447 
biopolymers in the gut environment.  448 
In conclusion, this study revealed that relevant changes in the populations of some major 449 
anaerobic intestinal bacterial groups as well as noticeable shifts in SCFA and lactic acid 450 
production can result from the presence of bifidobacterial EPS. Microbial population dynamics 451 
correlated well and supported the SCFA and lactic acid variations detected. EPS could reach the 452 
colon by two different ways: they could be either synthesized by probiotics in food products or by 453 
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intestinal bacteria in the intestinal environment, thus contributing to the modulation of the 454 
intestinal microbiota.  455 
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Table 1. FISH oligonucleotide probes used in this study.  
Probe Target sequence (5´- 3´) Target bacterial group/species Hybridisation 
T (ºC) 
References 
Erec 482 GCTTCTTAGTCARGTACCG Clostridium clusters XIVa +b 50 Franks et al. (1998) 
Bac 303 CCAATGTGGGGGACCTT Bacteroides-Prevotella group 46 Manz et al. (1996) 
Bif 164 CATCCGGCATTACCACCC Bifidobacterium genus 50 Langendijk et al. (1995) 
Lab158 GGTATTAGCAYCTGTTTCCA Lactobacillus-Enterococcus group 50 Harmsen et al. (1999) 
Ato 291 GGTCGGTCTCTCAACCC Atopobium cluster 50 Harmsen et al. (2000) 
Prop 853 ATTGCGTTAACTCCGGCAC Clostridium cluster IX 50 Walker et al. (2005) 
Chis 150 TTATGCGGTATTAATCTYCCTTT Clostridium histolyticum group 
clusters I, II 
50 Franks et al. (1998) 
Fpra 655 CGCCTACCTCTGCACTAC Part of Clostridium cluster IV  
(F. prausnitzii group)  
58 Hold et al. (2003) 
 
TABLE 2. Bacterial populations (Log cells/mL) in pH-controlled faecal batch cultures from three donors at 0, 10, 24, 34 and 48 hours using glucose, inulin or EPS as carbon 
sources.  †EPS R1 was isolated from a Bifidobacterium animalis strain of dairy origin and EPS E44 was obtained from a human strain of Bifidobacterium longum. Total 
bacterial counts were obtained using DAPI and bacterial groups by FISH probes indicated in Table 1. (*) Significantly different from negative control cultures within the 
same time point, with the same probe (P < 0.05). Substrates with different letters differ depending on the time of incubation, within the same substrate, with the same probe 
(P < 0.05).  
 
 
 
 Mean ± SD 
Carbon source Time 
(h) 
Total 
Bacteria 
Bifidobacterium 
genus 
Bacteroides-
Prevotella 
group 
Clostridium 
cluster 
XIVa+b 
Lactobacillus-
Enterococcus 
group 
Atopobium 
cluster 
C.histolyticum 
group 
Clostridium 
cluster IX 
F.prausnitzii 
group 
Control 
(without 
carbohydrate 
added) 
0 
10 
24 
34 
48 
8.99±0.10 
9.22±0.13 
9.15±0.07 
9.20±0.08 
9.13±0.04 
7.97±0.10 
7.82±0.23 
7.70±0.14 
7.52±0.32 
7.53±0.02 
8.43±0.27 
8.54±0.22 
8.49±0.24 
8.52±0.11 
8.21±0.54 
8.28±0.07 
7.95±0.32 
7.98±0.40 
7.94±0.34 
7.92±0.35 
6.86±0.14 
6.47±0.25 
6.60±0.15 
6.66±0.04 
6.65±0.26 
7.71±0.26b  
7.69±0.34
b
 
7.66±0.26b 
7.69±0.27b 
6.83±0.28a 
7.42±0.12a 
8.01±0.15
b
 
8.05±0.22b 
8.03±0.44b 
7.93±0.11b 
7.56±0.09 
7.59±0.42 
7.60±0.49 
7.77±0.39 
7.67±0.48 
6.84±0.25 
7.55±0.13 
7.52±0.44 
7.20±0.31 
7.12±0.24 
EPS-IPLA R1† 0 
10 
24 
34 
48 
8.98±0.13a 
9.22±0.12b 
9.27±0.08b 
9.22±0.11b 
9.17±0.04b 
8.01±0.10ab 
8.23±0.23b 
8.29±0.19b(*) 
8.28±0.22b(*) 
7.75±0.14a 
8.45±0.29 
8.57±0.42 
8.54±0.34 
8.74±0.54 
8.96±0.17(*) 
8.26±0.12 
8.15±0.15 
8.05±0.30 
7.86±0.56 
7.67±0.56 
6.84±0.11 
7.12±0.34(*) 
7.39±0.31(*) 
7.61±0.27(*) 
7.29±0.71 
7.64±0.25ab 
7.85±0.18b 
7.95±0.10b 
7.37±0.53ab 
6.90±0.47a 
7.43±0.09a 
7.88±0.16ab 
7.90±0.14b 
8.02±0.18b 
8.13±0.05b 
7.56±0.09a 
8.10±0.18b 
8.19±0.16b 
8.15±0.03b 
8.27±0.16b 
6.95±0.23 
7.08±0.11 
7.15±0.30 
7.02±0.69 
7.30±0.59 
EPS-E44 † 0 
10 
24 
34 
48 
9.00±0.13a 
9.22±0.11b 
9.37±0.07b 
9.37±0.13b 
9.09±0.14a 
8.00±0.10 
8.20±0.40 
8.30±0.19 (*) 
8.28±0.32 (*) 
7.65±0.23 
8.42±0.26 a 
8.66±0.37ab 
8.91±0.12 b 
9.02±0.06 b 
9.02±0.16 b(*) 
8.27±0.15 
8.22±0.26 
8.00±0.33 
7.84±0.43 
7.61±0.79 
6.84±0.08 
7.24±0.31(*) 
7.68±0.33(*) 
7.64±0.43(*) 
7.07±0.72 
7.70±0.27 
7.83±0.15 
7.92±0.08 
7.48±0.39 
7.80±0.40 
7.44±0.14a 
7.97±0.10b 
8.22±0.25b 
8.00±0.33b 
8.04±0.22b 
7.65±0.06 
7.77±0.21 
8.09±0.17 
8.15±0.36 
8.11±0.30 
6.75±0.26 
6.95±0.21 
7.48±0.48 
7.33±0.26 
7.30±0.31 
Inulin 0 
10 
24 
34 
48 
9.00±0.12 
9.12±0.01 
9.28±0.18 
9.36±0.27 
9.39±0.11 
8.00±0.10
ab
 
8.39±0.27b 
8.35±0.22b   (*) 
8.07±0.24ab (*) 
7.60±0.12a 
8.44±0.28
 a
 
8.63±0.20ab 
8.78±0.21ab 
8.97±0.14b 
9.00±0.16b(*) 
8.25±0.12 
8.16±0.22 
8.27±0.26 
8.22±0.28 
8.07±0.39 
6.84±0.09
a
 
7.41±0.24ab(*) 
7.69±0.21b  (*) 
7.78±0.08b (*) 
6.95±0.64a 
7.71±0.26 
7.89±0.15 
7.81±0.15 
7.58±0.12 
7.47±0.46 
7.43±0.16
a
 
7.97±0.12b 
7.95±0.20b 
8.05±0.16b 
8.03±0.13b 
7.58±0.10 
8.01±0.46 
8.10±0.20 
8.05±0.37 
8.04±0.15 
6.90±0.22 
7.35±0.28 
7.32±0.68 
7.25±0.82 
7.18±0.52 
Glucose 0 
10 
24 
34 
48 
8.99±0.10a 
9.29±0.02b 
9.33±0.14b 
9.21±0.11b 
9.13±0.18a 
7.99±0.10ab 
8.53±0.36b 
8.43±0.16b (*) 
8.26±0.23ab(*) 
7.92±0.09a  (*) 
8.40±0.28 
8.78±0.24 
8.71±0.09 
8.68±0.20 
8.52±0.17 
8.28±0.08 
7.96±0.16 
8.08±0.15 
7.99±0.22 
8.02±0.18 
6.82±0.11a 
7.26±0.23ab(*) 
7.47±0.14b  (*) 
7.56±0.49b  (*) 
6.85±0.29a 
7.66±0.24 
7.76±0.24 
7.68±0.05 
7.84±0.10 
7.20±0.60 
7.41±0.12a 
8.14±0.16b 
8.20±0.19b 
7.98±0.21b 
8.04±0.08b 
7.57±0.08a 
8.00±0.26b 
8.10±0.08b 
8.14±0.15b 
8.09±0.20b 
6.89±0.23 
6.91±0.59 
7.28±0.64 
7.12±0.35 
7.05±0.35 
Table 3. Concentrations (mM) of lactate and propionate in pH-controlled faecal batch cultures 
from three donors using glucose, inulin or EPS from bifidobacteria as carbon sources. * EPS R1 
was isolated from a Bifidobacterium animalis strain of dairy origin and EPS E44 was obtained from 
a human strain of Bifidobacterium longum. 
 
  Donor 1  Donor 2  Donor 3 
Carbon source Time 
(h) 
Lactate Propionate  Lactate Propionate  Lactate Propionate 
Control (without  
0 0.00 0.51 
 
0.00 0.20 
 
0.94 0.48 
carbohydrate  10 1.89 1.27  1.59 1.30  0.00 3.34 
added) 24 0.00 0.79  0.00 2.18  0.00 3.57 
 34 0.00 0.65  0.00 8.77  0.00 2.84 
 48 0.00 0.89  0.00 3.12  0.00 2.28 
 72 0.00 0.58  0.00 3.87  0.00 1.20 
          
EPS IPLA R1 * 0 0.48 0.42  0.58 0.48  1.05 0.63 
 10 2.32 0.55  3.30 0.82  2.29 6.76 
 24 0.85 5.97  0.75 2.87  0.26 13.52 
 34 1.89 7.42  0.65 2.45  0.00 12.74 
 48 0.83 8.77  0.00 3.82  0.00 13.05 
 72 0.97 11.44  0.00 5.08  0.00 13.62 
          
EPS E44 * 0 1.09 0.41  0.00 0.18  1.14 0.39 
 10 9.65 0.56  6.49 0.86  3.63 8.02 
 24 14.09 2.87  0.59 4.20  0.33 17.20 
 34 15.56 4.06  0.00 7.27  0.00 18.27 
 48 16.74 4.82  0.00 8.74  0.00 20.73 
 72 5.11 15.65  0.00 10.64  0.00 23.53 
          
Inulin 0 0.34 0.44  0.36 0.46  1.08 0.54 
 10 1.16 0.59  2.40 1.29  8.18 5.87 
 24 0.38 1.70  3.36 11.09  0.45 11.78 
 34 4.30 3.14  1.41 12.16  0.00 11.75 
 48 9.54 5.18  0.35 11.98  0.00 12.28 
 72 0.00 10.62  0.21 12.94  0.00 13.03 
          
Glucose 0 0.00 0.33  0.00 0.48  0.37 0.32 
 10 5.53 1.39  17.33 1.30  21.92 3.42 
 24 3.00 4.81  1.34 5.65  12.16 6.67 
 34 2.91 4.74  0.00 5.62  9.49 6.40 
 48 2.30 5.39  0.00 3.32  5.09 6.59 
 72 1.63 5.53  0.00 6.30  0.00 5.93 
TABLE 4. Molar concentration of total SCFA (mM) and percent of total SCFA for three major SCFA along with the ratio of acetate to propionate in pH-
controlled faecal batch cultures from three donors using glucose, inulin, or EPS as carbon sources. † EPS R1 was isolated from a Bifidobacterium animalis strain 
of dairy origin and EPS E44 was obtained from a human strain of Bifidobacterium. longum. A, acetate: P, propionate: B, butyrate 
602 
 Donor 1  Donor 2  Donor 3 
Carbon source  Time 
(h) 
A P B Ratio 
A/P 
Total 
SCFAs 
 A P B Ratio 
A/P 
Total 
SCFAs 
 A P B Ratio 
A/P 
Total 
SCFAs 
Control  0 63.69 36.31 0.00 1.75 1.41  84.84 15.16 0.00 5.60 1.33  77.06 22.94 0.00 3.36 2.08 
(without 10 82.20 17.80 0.00 4.62 7.16  78.17 21.83 0.00 3.58 5.95  78.32 17.58 4.10 4.46 19.00 
carbohydrate 24 87.22 12.78 0.00 6.83 6.16  81.28 18.72 0.00 4.34 11.64  85.01 14.99 0.00 5.67 23.84 
added) 34 87.30 9.79 2.91 8.92 6.61  65.43 33.85 0.72 1.93 25.91  80.38 19.62 0.00 4.10 14.46 
 48 86.73 13.27 0.00 6.54 6.72  79.34 19.97 0.69 3.97 15.62  47.47 52.53 0.00 0.90 4.34 
 72 87.36 12.64 0.00 6.91 4.61  78.21 21.79 1.40 3.59 17.76  51.27 48.73 0.00 1.05 2.46 
                   
EPS  IPLA R1 † 0 72.30 22.15 5.55 3.26 1.88  76.36 23.64 0.00 3.23 2.03  75.10 24.90 0.00 3.02 2.53 
 10 86.67 10.84 2.49 8.00 5.11  88.71 9.63 1.66 9.21 8.47  69.42 28.16 2.41 2.47 24.02 
 24 65.64 32.33 2.02 2.03 18.47  82.05 17.34 0.61 4.73 16.52  63.04 31.68 5.28 1.99 42.66 
 34 65.58 33.92 0.49 1.93 21.86  85.65 13.60 0.75 6.30 18.00  63.26 32.05 4.69 1.97 39.73 
 48 65.39 33.83 0.78 1.93 25.85  79.17 18.80 2.03 4.21 20.33  62.54 31.77 5.69 1.97 41.07 
 72 67.17 31.71 1.12 2.12 36.04  44.95 44.36 10.69 1.01 11.46  62.68 30.05 7.26 2.09 45.30 
                   
EPS  E44 † 0 64.05 27.11 8.84 2.36 1.51  83.02 16.98 0.00 4.89 1.05  90.10 9.90 0.00 9.10 3.91 
 10 94.47 4.40 1.13 21.49 12.85  89.82 8.77 1.41 10.24 9.82  73.16 26.84 0.00 2.73 29.88 
 24 84.50 13.25 2.25 6.38 21.70  75.70 21.59 2.71 3.51 19.44  59.15 36.91 3.94 1.60 46.60 
 34 80.68 16.80 2.51 4.80 24.17  70.19 27.59 2.22 2.54 26.37  57.98 37.77 4.25 1.54 48.39 
 48 77.46 17.31 5.23 4.48 27.87  66.13 29.58 4.29 2.24 29.56  55.73 39.51 4.76 1.41 52.48 
 72 56.36 39.67 3.97 1.42 39.45  57.89 31.90 10.21 1.81 33.35  54.47 38.96 6.57 1.40 60.39 
                   
Inulin 0 70.83 29.17 0.00 2.43 1.50  63.99 25.01 11.00 2.56 1.83  78.45 17.90 3.64 4.38 3.02 
 10 72.51 13.51 13.98 5.37 4.34  82.05 12.31 5.64 6.67 10.48  62.52 21.78 15.70 2.87 26.96 
 24 70.86 10.91 18.23 6.50 15.60  61.96 26.97 11.07 2.30 41.12  50.70 32.58 16.71 1.56 36.15 
 34 58.51 13.99 27.50 4.18 31.48  61.34 27.50 11.15 2.23 44.22  49.76 32.22 18.01 1.54 36.45 
 48 59.90 17.22 22.88 3.48 30.05  59.66 26.48 13.86 2.25 45.24  49.56 33.08 17.36 1.50 37.13 
 72 50.63 30.36 19.02 1.67 35.00  59.01 26.67 14.32 2.21 48.51  47.17 32.70 20.13 1.44 39.85 
                   
Glucose 0 87.56 12.44 0.00 7.04 2.65  62.92 37.08 0.00 1.70 1.28  87.24 12.76 0.00 6.84 2.52 
 10 90.56 9.44 0.00 9.60 14.77  93.40 6.60 0.00 14.15 19.66  89.00 10.37 0.63 8.59 32.95 
 24 79.36 20.64 0.00 3.84 23.30  67.59 22.05 10.36 3.07 25.62  76.76 16.81 6.43 4.57 39.69 
 34 76.87 20.59 2.54 3.73 23.01  66.47 21.67 11.86 3.07 25.91  73.69 16.49 9.82 4.47 38.83 
 48 74.91 22.23 2.86 3.37 24.23  72.32 13.84 13.84 5.22 23.98  68.23 17.28 14.49 3.95 38.11 
 72 74.13 21.99 3.88 3.37 25.17  64.59 22.41 13.00 2.88 28.12  59.80 16.95 23.25 3.53 34.98 
Legends 603 
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Figure 1. Chemically simulated gastric and intestinal transit of the EPS fractions isolated from B. 606 
longum subsp. longum IPLA E44 and B. animalis subsp. lactis IPLA R1 represented as the average 607 
amount of EPS determined by SEC before simulation (white bars), after gastric digestion (grey 608 
bars) and after intestinal digestion (black bars). Vertical lines indicate standard deviation. 609 
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